This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Swantek, J. L. Articles by Baserga, R. Search for Related Content PubMed PubMed Citation Articles by Swantek, J. L. Articles by Baserga, R. Pubmed/NCBI databases Substance via MeSH

Prolonged Activation of ERK2 by Epidermal Growth Factor and Other Growth Factors Requires a Functional Insulin-Like Growth Factor 1 Receptor¹

Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107

Address all correspondence and requests for reprints to: Jennifer L. Swantek, Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas 75235.

We have investigated the activation of ERK2, a serine/threonine kinase necessary for transmission of mitogenic signals, in cells derived from mouse embryos homozygous for a null mutation of the insulin-like growth factor (IGF)-1R gene (R^- cells) and from wild-type littermates (W cells), respectively. Stimulation of quiescent W cells with IGF-1, epidermal growth factor (EGF), or with a combination growth factors induced both a maximal transient and a prolonged activation of ERK2, whereas platelet-derived growth factor or a combination of platelet-derived growth factor and EGF resulted only in transient activation of ERK2. In contrast, stimulation of R^- cells with IGF-1, EGF, or combinations of growth factors resulted in a transient and submaximal activation of ERK2. Reintroduction of a wild-type human IGF-1R or of a C-terminus IGF-1R mutant, but not of a juxtamembrane mutant IGF-1R, into R^- cells was able to restore ERK2 activation to wild-type levels. Thus, prolonged ERK2 activation in mouse embryo fibroblasts stimulated with purified growth factors is largely dependent on a signal generated by the IGF-1R.

This article has been cited by other articles:

				A. K. Chakraborty, K. Liang, and M. P. DiGiovanna Co-Targeting Insulin-Like Growth Factor I Receptor and HER2: Dramatic Effects of HER2 Inhibitors on Nonoverexpressing Breast Cancer Cancer Res., March 1, 2008; 68(5): 1538 - 1545. [Abstract] [Full Text] [PDF]

				J. Cheng and J. Du Mechanical Stretch Simulates Proliferation of Venous Smooth Muscle Cells Through Activation of the Insulin-Like Growth Factor-1 Receptor Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1744 - 1751. [Abstract] [Full Text] [PDF]

				H. M. El-Shewy, F. L. Kelly, L. Barki-Harrington, and L. M. Luttrell Ectodomain Shedding-Dependent Transactivation of Epidermal Growth Factor Receptors in Response to Insulin-Like Growth Factor Type I Mol. Endocrinol., November 1, 2004; 18(11): 2727 - 2739. [Abstract] [Full Text] [PDF]

				U. Sivaprasad, J. Fleming, P. S. Verma, K. A. Hogan, G. Desury, and W. S. Cohick Stimulation of Insulin-Like Growth Factor (IGF) Binding Protein-3 Synthesis by IGF-I and Transforming Growth Factor-{alpha} Is Mediated by Both Phosphatidylinositol-3 Kinase and Mitogen-Activated Protein Kinase Pathways in Mammary Epithelial Cells Endocrinology, September 1, 2004; 145(9): 4213 - 4221. [Abstract] [Full Text] [PDF]

				T. Ahmad, G. Farnie, N. J. Bundred, and N. G. Anderson The Mitogenic Action of Insulin-like Growth Factor I in Normal Human Mammary Epithelial Cells Requires the Epidermal Growth Factor Receptor Tyrosine Kinase J. Biol. Chem., January 16, 2004; 279(3): 1713 - 1719. [Abstract] [Full Text] [PDF]

				Y. Li, Y. Higashi, H. Itabe, Y.-H. Song, J. Du, and P. Delafontaine Insulin-Like Growth Factor-1 Receptor Activation Inhibits Oxidized LDL-Induced Cytochrome C Release and Apoptosis via the Phosphatidylinositol 3 Kinase/Akt Signaling Pathway Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2178 - 2184. [Abstract] [Full Text] [PDF]

				A. Hurbin, L. Dubrez, J.-L. Coll, and M.-C. Favrot Inhibition of Apoptosis by Amphiregulin via an Insulin-like Growth Factor-1 Receptor-dependent Pathway in Non-small Cell Lung Cancer Cell Lines J. Biol. Chem., December 13, 2002; 277(51): 49127 - 49133. [Abstract] [Full Text] [PDF]

				M. A. Stull, M. M. Richert, A. V. Loladze, and T. L. Wood Requirement for IGF-I in Epidermal Growth Factor-Mediated Cell Cycle Progression of Mammary Epithelial Cells Endocrinology, May 1, 2002; 143(5): 1872 - 1879. [Abstract] [Full Text] [PDF]

				M. Bartucci, C. Morelli, L. Mauro, S. Ando', and E. Surmacz Differential Insulin-like Growth Factor I Receptor Signaling and Function in Estrogen Receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 Breast Cancer Cells Cancer Res., September 1, 2001; 61(18): 6747 - 6754. [Abstract] [Full Text] [PDF]

				M. Dews, M. Prisco, F. Peruzzi, G. Romano, A. Morrione, and R. Baserga Domains of the Insulin-Like Growth Factor I Receptor Required for the Activation of Extracellular Signal-Regulated Kinases Endocrinology, April 1, 2000; 141(4): 1289 - 1300. [Abstract] [Full Text] [PDF]

				D. Krause, A. Lyons, C. Fennelly, and R. O'Connor Transient Activation of Jun N-terminal Kinases and Protection from Apoptosis by the Insulin-like Growth Factor I Receptor Can Be Suppressed by Dicumarol J. Biol. Chem., May 25, 2001; 276(22): 19244 - 19252. [Abstract] [Full Text] [PDF]